Clinical Trial Update: Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and early effectiveness signals for BNT327 in combination with chemotherapy for small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• BNT327

Snippet

Sponsor: BioNTech SE | Conditions: Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING